Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
120 participants
INTERVENTIONAL
2015-02-28
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Nausea and Vomiting and Acupuncture/Acupressure
NCT00965367
Dexamethasone Versus Local Infiltration Technique for Tonsillectomy in Children
NCT02355678
Acupuncture and Nausea/Vomiting in Pediatric Patients
NCT01417741
Preemptive Dexamethasone , Paracetamol on Postoperative Period Following Adeno-tonsillectomy in Pediatric .
NCT05143762
Nebulized Versus Intravenous Dexmedetomidine for Sevoflurane Induced Emergence Agitation After Pediatric Tonsillectomy
NCT05641376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Dexamethasone (0.15 mg/kg) immediately after induction of anaesthesia
* Acupuncture treatment (immediately after induction of anaesthesia and for approximately 20 minutes)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dexamethasone
Patients will receive Intravenous dexamethasone 0.15 mg/kg immediately after induction of anesthesia.
Dexamethasone
Patients will receive Intravenous dexamethasone 0.15 mg/kg immediately after induction of anesthesia.
Acupuncture
Acupuncture at point Neiguan (Pericardium-6) bilaterally and at point CV13 (Shang Wen) with acupuncture needles (0.25x25 mm) to a depth of approximately 7 mm will be performed on the children immediately after induction of anaesthesia and removed after 20 minutes
Acupuncture
Acupuncture treatment (just after induction of anaesthesia and for approximately 20 minutes)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexamethasone
Patients will receive Intravenous dexamethasone 0.15 mg/kg immediately after induction of anesthesia.
Acupuncture
Acupuncture treatment (just after induction of anaesthesia and for approximately 20 minutes)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* children ASA 1-2
* tonsillectomy with or without adenoidectomy
Exclusion Criteria
* intravenous induction
* contraindication to steroids
* Rash or local infection over an acupuncture point
* administration of steroids in the 24 hours before the surgery
* Use of medication with antiemetic effect within the 24 hours before surgery
* Gastric or intestinal diseases
* refusal of parents
2 Years
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seham Mohamed Moeen Ibrahim
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seham Ibrahim, Lecturer
Role: PRINCIPAL_INVESTIGATOR
health,Higher education
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Assuit University
Egypt, Assuit, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SM2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.